Pattern of relapses in Iranian patients with ulcerative colitis. A prospective study

Journal of Gastrointestinal and Liver Diseases

Volumn 15, Issue 4, 2006, Pages 355-358

  Daryani, Nasser Ebrahimi ^a   Bashashati, Mohammad ^a   Aram, Setareh ^a   Hashtroudi, Ali Asad ^a   Shakiba, Madjid ^a   Sayyah, Alireza ^a   Nayer Habibi, Atoosa ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iran; Relapse pattern; Ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; RELAPSE; TIME; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; COLITIS, ULCERATIVE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 33846316331     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol 2005;20: 1695.
2. Mir-Madjlessi SH, Forouzandeh B, Ghadimi R. Ulcerative colitis in Iran: a review of 112 cases. Am J Gastroenterol 1985;80: 862-866.
3. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999;28: 255-281
4. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3-11.
5. Hanauer SB. Inflammatory bowel disease. N Engl J Med 1996;334: 841-848.
6. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955;2: 1041-1048.
7. Selby W. The natural history of ulcerative colitis. Baillieres Clin Gastroenterol 1997; 11: 53-64.
8. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Pre-cancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31: 800-806
9. Moayyeri A, Daryani NE, Bahrami H, Haghpanah B, Nayyer-Habibi A, Sadatsafavi M. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis. J Gastroenterol Hepatol 2005;20: 366-370.
10. Stewenius J, Adnerhill I, Ekelund GR et al. Risk of relapse in new cases of ulcerative colitis and indeterminate colitis. Dis Colon Rectum 1996;39: 1019-1025.
11. Bresci G, Parisi G, Bertoni M, Capria A. Long-term maintenance treatment in ulcerative colitis: a 10-year follow-up. Dig Liver Dis 2002;34: 419-423
12. Bitton A, Peppercorn MA, Antonioli DA et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 2001; 120:13-20.
13. Ritchie JK, Powell-Tuck J, Lennard-Jones JB. Clinical outcome of the first ten years of ulcerative colitis and proctitis. Lancet 1978; 1:1140-1143.
14. Riley SA, Mani V, Goodman MJ, Lucas S. Why do patients with ulcerative colitis relapse? Gut 1990;31: 179-183
15. Ayres RC, Gillen CD, Walmsley RS, Allan RN. Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression. Eur J Gastroenterol Hepatol 1996; 8:555-558.